Mig and IP-10: CXC chemokines that target lymphocytes

被引:670
|
作者
Farber, JM
机构
[1] Laboratory of Clinical Investigation, Natl. Inst. Allerg. and Infect. Dis., National Institutes of Health, Bethesda, MD
[2] Bldg. 10, NIH, Bethesda, MD 20892
关键词
cytokines; interferon; T cells; infection; angiogenesis; cancer;
D O I
10.1002/jlb.61.3.246
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mg and IP-10 are related members of the CXC subfamily of the chemokine family of cytokines. The murine Mig (MuMig), human IP-10, and the mouse homologue of IP-10, Crg-2, were all identified due to the dramatic inductions of their genes in monocytic cells treated with interferon-gamma (IFN-gamma), Studies using recombinant (r) human proteins show that, unlike most other CXC chemokines, rHuMig and rIP-10 have no activity on neutrophils but appear to target lymphocytes specifically, rHuMig and rIP-10 are active as chemotactic factors for stimulated, but not for resting, T cells, Studies done in vitro and in vivo have shown that rHuMig and rIP-10 share additional activities, including inhibition of neovascularization, inhibition of hematopoietic progenitor cells, and anti-tumor effects, rHuMig and rIP-10 show reciprocal desensitization on activated T cells and have been demonstrated to share a receptor, CXCR3, The genes for both MuMig, and Crg-2 are highly expressed in multiple tissues during experimental viral and protozoan infections in mice, but their patterns of expression differ, This suggests that the Migs and IP-10/Crg-2 may play roles in host defense and that, despite their similar activities assayed in vitro, Mig and IP-10/Crg-2 may serve non-redundant functions in vivo.
引用
收藏
页码:246 / 257
页数:12
相关论文
共 50 条
  • [1] The CXC chemokines IP-10 and Mig are essential in host Defense following infection with a neurotropic coronavirus
    Liu, MT
    Chen, BP
    Oertel, P
    Buchmeier, MJ
    Hamilton, TA
    Armstrong, DA
    Lane, TE
    [J]. NIDOVIRUSES (CORONAVIRUSES AND ARTERIVIRUSES), 2001, 494 : 323 - 327
  • [2] CXC chemokines Groα/IL-8 and IP-10/MIG in Helicobacter pylori gastritis
    Eck, M
    Schmausser, B
    Scheller, K
    Toksoy, A
    Kraus, M
    Menzel, T
    Müller-Hermelink, HK
    Gillitzer, R
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (02): : 192 - 199
  • [3] The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor
    Tannenbaum, CS
    Tubbs, R
    Armstrong, D
    Finke, JH
    Bukowski, RM
    Hamilton, TA
    [J]. JOURNAL OF IMMUNOLOGY, 1998, 161 (02): : 927 - 932
  • [4] Differential expression of IFN-γ induced CXC chemokines IP-10 and MIG in inflammatory skin diseases.
    Flier, J
    Boorsma, DM
    van Beek, PJ
    Stoff, TJ
    Willemze, R
    Tensen, CP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 658 - 658
  • [5] The angiostatic CXC chemokines, IP-10 and MIG are reduced during the pathogenesis of bleomycin-induced pulmonary fibrosis
    Arenberg, D
    Burdick, M
    Wilke, C
    Morris, S
    Glass, M
    Kunkel, S
    Strieter, R
    [J]. FASEB JOURNAL, 1997, 11 (03): : 1325 - 1325
  • [6] Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors
    Sun, H
    Kundu, N
    Dorsey, R
    Jackson, MJ
    Fulton, AM
    [J]. JOURNAL OF IMMUNOTHERAPY, 2001, 24 (02): : 138 - 143
  • [7] Induction of the CXC chemokines IP-10 and MIG in patients (PTS) receiving rHuIL-12 or rIL-2.
    Bukowski, RM
    Don, W
    Redovan, C
    McLain, D
    Sandstrom, K
    Olencki, T
    Budd, GT
    Peereboom, D
    Griffin, T
    Tannenbaum, C
    Finke, JK
    [J]. BLOOD, 1996, 88 (10) : 1247 - 1247
  • [8] The chemokines IP-10 and MIG identified as mediators of tumor necrosis in vivo
    Sgadari, C
    Angiolillo, A
    Farber, J
    TeruyaFeldstein, J
    Burd, P
    Tosato, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 107 - 107
  • [9] Glutamine and CXC chemokines IL-8, Mig, IP-10 and I-TAC in human intestinal epithelial cells
    Marion, R
    Coëffier, M
    Gargala, G
    Ducrotté, P
    Déchelotte, P
    [J]. CLINICAL NUTRITION, 2004, 23 (04) : 579 - 585
  • [10] PPARγ activators selectively inhibit the IFNγ-inducible CXC chemokines IP-10, mig, and I-TAC in endothelial cells
    Mach, FA
    Marx, N
    Sauty, A
    Luster, AD
    Plutzky, J
    [J]. CIRCULATION, 1999, 100 (18) : 615 - 615